|1.||Schönherr, Holger: 2 articles (09/2015 - 07/2014)|
|2.||Sadat Ebrahimi, Mir-Morteza: 1 article (09/2015)|
|3.||Voss, Yvonne: 1 article (09/2015)|
|4.||Sadat Ebrahimi, Mir Morteza: 1 article (07/2014)|
|5.||Nagy, György: 1 article (01/2013)|
|6.||Tóth, Kálmán: 1 article (01/2013)|
|7.||Wellinger, Károly: 1 article (01/2013)|
|8.||Falus, András: 1 article (01/2013)|
|9.||Misják, Petra: 1 article (01/2013)|
|10.||Pálóczi, Krisztina: 1 article (01/2013)|
|1.||Urinary Tract Infections (Urinary Tract Infection)
12/01/2007 - "Examples of target pathogens include Staphylococcus aureus, Streptococcus agalactiae, Salmonella spp. and Candida spp. The inclusion of multiple chromogenic substrates into culture media facilitates the differentiation of polymicrobial cultures, thus allowing for the development of improved media for diagnosis of urinary tract infections and media for the enhanced discrimination of yeasts. "
|3.||Schoenlein-Henoch Purpura (Purpura, Schoenlein Henoch)
|4.||Wounds and Injuries (Trauma)
06/01/2011 - "HNE and CatG activities were monitored directly in wound fluid via hydrolysis of the chromogenic substrates. "
09/16/2015 - "Under optimized conditions, the 4-methylumbelliferyl-β-D-glucuronide-functionalized hydrogel reported the presence of β-GUS within 15 min with a limit of detection of <1 nM. Finally, the function of the generally applicable hydrogel-film-based sensing approach, which is compatible with polymer-film-based applications, including wound dressings and packaging materials, and is also amenable to address noncultivatable pathogenic bacteria by using appropriate fluorogenic or chromogenic substrates, was demonstrated by direct application with bacterial medium."
07/08/2014 - "Under optimized conditions the hydrogel reports the presence of α-chymotrypsin in <5 min with a limit of detection of ≤10 nM. This generic approach, which can be adapted to detect different kinds of enzymes by using appropriate fluorogenic or chromogenic substrates, is highly interesting for targeting the detection of specific pathogenic bacteria, e.g., in wound dressings. "
|5.||Cystic Fibrosis (Mucoviscidosis)
04/01/1986 - "The results indicate that determination of salivary protease activity using chromogenic substrates may give additional information in patients with suspected cystic fibrosis, and indicate the possibility of an additional diagnostic test."
04/01/1986 - "The protease activities in saliva from individuals with cystic fibrosis (CF) were studied using four different chromogenic substrates. "
04/01/1986 - "Cystic fibrosis: protease activity in saliva evaluated with chromogenic substrates."
02/21/2008 - "Novel 7-N-(beta-alanyl)aminophenoxazin-3-one salts 27a-d have been synthesized and tested as chromogenic substrates for beta-alanyl aminopeptidase, which is present in Pseudomonas aeruginosa, the most common respiratory pathogen in patients with cystic fibrosis. "
|7.||CD13 Antigens (Alanine Aminopeptidase)
|8.||Plasminogen Activator Inhibitor 1
|10.||Interleukin-6 (Interleukin 6)